Recent advances in the construction of antibody-drug conjugates

Nature Chemistry
Vijay ChudasamaStephen Caddick

Abstract

Antibody-drug conjugates (ADCs) comprise antibodies covalently attached to highly potent drugs using a variety of conjugation technologies. As therapeutics, they combine the exquisite specificity of antibodies, enabling discrimination between healthy and diseased tissue, with the cell-killing ability of cytotoxic drugs. This powerful and exciting class of targeted therapy has shown considerable promise in the treatment of various cancers with two US Food and Drug Administration approved ADCs currently on the market (Adcetris and Kadcyla) and approximately 40 currently undergoing clinical evaluation. However, most of these ADCs exist as heterogeneous mixtures, which can result in a narrow therapeutic window and have major pharmacokinetic implications. In order for ADCs to deliver their full potential, sophisticated site-specific conjugation technologies to connect the drug to the antibody are vital. This Perspective discusses the strategies currently used for the site-specific construction of ADCs and appraises their merits and disadvantages.

References

Dec 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C S GreenbergR H Rice
May 1, 1972·Cancer·T Ghose, S P Nigam
Jan 1, 1994·Journal of Drug Targeting·G A Pietersz, K Krauer
Sep 11, 2002·The Journal of Biological Chemistry·Tatsuki KashiwagiEi-ichiro Suzuki
Jun 5, 2003·Nature Biotechnology·Svetlana O DoroninaPeter D Senter
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kevin J HamblettJoseph A Francisco
May 21, 2005·Biotechnology Progress·Royston Jefferis
Sep 22, 2005·Bioconjugate Chemistry·Michael M C SunStephen C Alley
Jan 31, 2008·Journal of Immunological Methods·Jagath R JunutulaHenry B Lowman
Jul 22, 2008·Nature Biotechnology·Jagath R JunutulaWilliam Mallet
Feb 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Peng WuCarolyn R Bertozzi
Aug 14, 2009·Organic & Biomolecular Chemistry·Murat Sunbul, Jun Yin
Oct 27, 2009·Journal of Molecular Biology·Travis S YoungPeter G Schultz
Nov 5, 2010·The New England Journal of Medicine·Anas YounesAndres Forero-Torres
Jan 25, 2011·Molecular Immunology·Weirong WangRoxana Ionescu
Oct 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patricia M LoRussoMark X Sliwkowski
May 12, 2012·Nature Protocols·David RabukaCarolyn R Bertozzi
Sep 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jun Y AxupPeter G Schultz
Oct 2, 2012·The New England Journal of Medicine·Sunil VermaUNKNOWN EMILIA Study Group
May 1, 2013·Nature Reviews. Drug Discovery·Asher Mullard
Sep 28, 2013·Bioconjugate Chemistry·Nia S BeckleyHeather L Flores
Jan 21, 2014·Proceedings of the National Academy of Sciences of the United States of America·Feng TianPuja Sapra
Feb 19, 2014·Bioconjugate Chemistry·Qun ZhouClark Q Pan
May 6, 2014·Bioconjugate Chemistry·George BadescuAntony Godwin
Apr 1, 2015·Nature Communications·Antoine MaruaniStephen Caddick
Jun 9, 2015·Chemical Communications : Chem Comm·João P M NunesVijay Chudasama
Jan 1, 2016·Chemical Science·Maximillian T W LeeVijay Chudasama

❮ Previous
Next ❯

Citations

Feb 6, 2016·International Journal of Molecular Sciences·Houzong YaoGe Zhang
Apr 27, 2016·Journal of the American Chemical Society·Todd M DoranThomas Kodadek
Oct 12, 2016·ACS Central Science·Peng DaiBradley L Pentelute
Nov 1, 2016·Journal of the American Chemical Society·Tomonori KobayashiLei Wang
Jan 11, 2018·Journal of Cellular Physiology·Hadi NasiriJafar Majidi
Oct 27, 2017·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Eden R PadayacheeStefan Barth
May 29, 2018·Organic & Biomolecular Chemistry·Rahul NisalJeet Kalia
Jun 16, 2018·Chemical Communications : Chem Comm·Maheshwerreddy ChilamariVishal Rai
Aug 7, 2018·Advanced Healthcare Materials·Lingyun ZhouShu Wang
Jun 13, 2018·Chemistry : a European Journal·Guhuan LiuShiyong Liu
Dec 13, 2018·Organic & Biomolecular Chemistry·Shuang SunGonçalo J L Bernardes
Nov 25, 2018·Nature Protocols·Barbara BernardimGonçalo J L Bernardes
Jan 31, 2018·Scientific Reports·Makan KhoshnejadVladimir R Muzykantov
Nov 7, 2018·Angewandte Chemie·Chi ZhangBradley L Pentelute
Mar 12, 2019·Angewandte Chemie·Kei YamadaBrian A Mendelsohn
Oct 27, 2016·Nature Communications·Barbara BernardimGonçalo J L Bernardes
May 14, 2019·Environmental Science and Pollution Research International·Carmen RaclesVasile Cozan
Sep 20, 2017·Pharmaceutical Research·Paul MalikJonathan Blay
Jun 30, 2019·Angewandte Chemie·Marc-André KasperChristian P R Hackenberger
Jul 30, 2019·Biomaterials Science·Ghazal FarahavarForoogh Nejatollahi
Nov 27, 2019·Chemical Communications : Chem Comm·Sangeeta ParmarDimpy Kalia
Feb 20, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yoshiko Miura
Feb 27, 2020·Organic & Biomolecular Chemistry·Johnathan C MazaMatthew B Francis
Mar 4, 2020·Biomolecules·Kelvin K TsaoJeffrey W Keillor
May 21, 2020·Organic & Biomolecular Chemistry·Stephen J WalshDavid R Spring
Nov 26, 2019·Chemical Communications : Chem Comm·Calise BahouVijay Chudasama
Jul 17, 2020·Chemical Communications : Chem Comm·Tiantian WuYangzhong Liu
Jul 24, 2020·Journal of Drug Targeting·Zhijing HeGuangxi Zhai
Jan 23, 2016·Nature Chemistry·Yichao Huang, Lei Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

© 2022 Meta ULC. All rights reserved